PUBLICATIONS · 17470858
Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2007 May 1
- First author
- Van Cutsem E
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2007 May 1;25(13):1639-41. doi: 10.1200/JCO.2006.09.8384.
- note
- Source null
- related pmid
- 17470854
- relationship
- Comment in
- citation
- J Clin Oncol. 2007 Oct 10;25(29):4691-2; author reply 4692. doi: 10.1200/JCO.2007.12.7613.
- note
- Source null
- related pmid
- 17925568
- relationship
- Comment in
Authors and identifiers
- name
- Van Cutsem E
- type
- Author
- name
- Peeters M
- type
- Author
- name
- Siena S
- type
- Author
- name
- Humblet Y
- type
- Author
- name
- Hendlisz A
- type
- Author
- name
- Neyns B
- type
- Author
- name
- Canon JL
- type
- Author
- name
- Van Laethem JL
- type
- Author
- name
- Maurel J
- type
- Author
- name
- Richardson G
- type
- Author
- name
- Wolf M
- type
- Author
- name
- Amado RG
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Van Cutsem E
- type
- Author
- name
- Peeters M
- type
- Author
- name
- Siena S
- type
- Author
- name
- Humblet Y
- type
- Author
- name
- Hendlisz A
- type
- Author
- name
- Neyns B
- type
- Author
- name
- Canon JL
- type
- Author
- name
- Van Laethem JL
- type
- Author
- name
- Maurel J
- type
- Author
- name
- Richardson G
- type
- Author
- name
- Wolf M
- type
- Author
- name
- Amado RG
- type
- Author
- bibliography ids
- nci-bib-8a61530faf1af146367f11bd
- book metadata
- content sha256
- f9b8a5829756a584154a4d83effa6b793680069363c86ebc15e3a094527ed4bd
- document type
- citation
- dois
- 10.1200/JCO.2006.08.1620
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:17470858
- immutable id
- pubmed:17470858@f9b8a5829756a584154a4d83effa6b793680069363c86ebc15e3a094527ed4bd
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 13
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1658-64
- volume
- 25
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2007 May 1;25(13):1639-41. doi: 10.1200/JCO.2006.09.8384.
- note
- Source null
- related pmid
- 17470854
- relationship
- Comment in
- citation
- J Clin Oncol. 2007 Oct 10;25(29):4691-2; author reply 4692. doi: 10.1200/JCO.2007.12.7613.
- note
- Source null
- related pmid
- 17925568
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 17470858
- provenance
- batch id
- de363a11f4b1613edab0
- provider
- NCBI PubMed ESummary
- record sha256
- bbce9e990b5c3aab991c83b70cb07e385ebb062c8a0f8b1bba66e12ac9808025
- response sha256
- a83f066085229c55d3d0ec880c129c835ac872440e73f5fc2b7131ecfb2a254f
- retrieved at
- 2026-09-09T23:46:14.107379+00:00
- publication date
- display
- 2007 May 1
- precision
- day
- year
- 2007
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle